Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Kiromic Biopharma, Inc. (KRBP) Class Action Lawsuit (August 2022)

Settlement

1:22cv6690 • August 5, 2022

Class Period Start

June 25, 2021

Class Period End

February 2, 2022

PSLRA Deadline

October 4, 2022

Case Allegations

10b5 + Sec11

10b-5 Statutes of Repose

Jun 25, 2024

Sec11 Statutes of Repose

Jun 25, 2024

Country

United States

Court

Federal Court

Settlement Information

Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.

Claim Deadline

December 31, 1969

Settlement Fund

$0

Settlement Status

Preliminarily Approved

Settlement Class

Claim Administrator




Settlement Website

Hearing Date

December 31, 1969

Opt-out Deadline

December 31, 1969

Settlement Note

Download here

Proof Of Claim

Download here

Docket History

Aug 25, 2026

Preliminary Approval of Settlement

The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.

May 18, 2026

Motion for Preliminary Approval of Settlement

The parties have asked the court to give preliminary approval to a proposed settlement. The judge will review the request and decide whether the settlement can move forward to the next stage. If approved, potential class members will generally receive information about the settlement and their rights, including any deadlines for taking action.

Sep 29, 2023

Motion for Preliminary Approval of Settlement

The parties have asked the court to give preliminary approval to a proposed settlement. The judge will review the request and decide whether the settlement can move forward to the next stage. If approved, potential class members will generally receive information about the settlement and their rights, including any deadlines for taking action.

Feb 6, 2023

Scheduling Order

Dec 21, 2022

First Amended Complaint

A new complaint has been filed on behalf of certain investors in Kiromic Biopharma, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Oct 27, 2022

Appointment of Lead Plaintiff

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Aug 5, 2022

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in Kiromic Biopharma, Inc..

TOP